Shares of Vitamin Shoppe, Inc (NYSE:VSI) have been assigned an average rating of “Hold” from the twelve analysts that are currently covering the firm, MarketBeat reports. Four investment analysts have rated the stock with a sell rating and seven have issued a hold rating on the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $12.57.
Several analysts have recently commented on the company. ValuEngine downgraded Vitamin Shoppe from a “buy” rating to a “hold” rating in a research note on Friday. Bank of America Corporation reissued an “underperform” rating and issued a $5.00 price objective (down from $5.50) on shares of Vitamin Shoppe in a research note on Wednesday, August 23rd. Zacks Investment Research downgraded Vitamin Shoppe from a “hold” rating to a “sell” rating in a research note on Tuesday, August 15th. TheStreet downgraded Vitamin Shoppe from a “c-” rating to a “d” rating in a research note on Wednesday, August 9th. Finally, Morgan Stanley set a $8.00 price target on Vitamin Shoppe and gave the company a “hold” rating in a research report on Thursday, August 10th.
Shares of Vitamin Shoppe (NYSE VSI) traded down 4.67% during midday trading on Tuesday, reaching $5.10. The company had a trading volume of 649,051 shares. The stock’s market capitalization is $118.44 million. The stock’s 50 day moving average is $8.11 and its 200-day moving average is $14.02. Vitamin Shoppe has a 12-month low of $4.95 and a 12-month high of $28.41.
Vitamin Shoppe (NYSE:VSI) last issued its quarterly earnings data on Wednesday, August 9th. The specialty retailer reported $0.23 EPS for the quarter, missing the consensus estimate of $0.39 by $0.16. The company had revenue of $304.84 million during the quarter, compared to analysts’ expectations of $314.74 million. Vitamin Shoppe had a positive return on equity of 8.33% and a negative net margin of 11.98%. The business’s revenue for the quarter was down 8.4% compared to the same quarter last year. During the same period last year, the company earned $0.55 earnings per share. On average, equities research analysts predict that Vitamin Shoppe will post $0.79 earnings per share for the current fiscal year.
TRADEMARK VIOLATION WARNING: This story was posted by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this story on another publication, it was copied illegally and reposted in violation of US and international copyright legislation. The legal version of this story can be read at https://stocknewstimes.com/2017/09/20/vitamin-shoppe-inc-vsi-given-consensus-rating-of-hold-by-analysts.html.
In other Vitamin Shoppe news, Director John D. Bowlin purchased 40,000 shares of the firm’s stock in a transaction that occurred on Friday, August 25th. The stock was bought at an average cost of $5.50 per share, with a total value of $220,000.00. Following the completion of the transaction, the director now owns 56,028 shares of the company’s stock, valued at approximately $308,154. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 1.07% of the company’s stock.
Hedge funds and other institutional investors have recently made changes to their positions in the business. Comerica Bank grew its holdings in Vitamin Shoppe by 37.8% during the first quarter. Comerica Bank now owns 35,339 shares of the specialty retailer’s stock valued at $689,000 after purchasing an additional 9,685 shares during the period. Aperio Group LLC bought a new position in Vitamin Shoppe during the second quarter valued at $402,000. Teachers Advisors LLC grew its holdings in Vitamin Shoppe by 4.7% during the first quarter. Teachers Advisors LLC now owns 63,691 shares of the specialty retailer’s stock valued at $1,283,000 after purchasing an additional 2,887 shares during the period. First Trust Advisors LP bought a new position in Vitamin Shoppe during the first quarter valued at $549,000. Finally, Principal Financial Group Inc. grew its holdings in Vitamin Shoppe by 3.7% during the first quarter. Principal Financial Group Inc. now owns 181,564 shares of the specialty retailer’s stock valued at $3,659,000 after purchasing an additional 6,408 shares during the period. 96.86% of the stock is owned by institutional investors and hedge funds.
About Vitamin Shoppe
Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.
Receive News & Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related companies with MarketBeat.com's FREE daily email newsletter.